Navigation Links
Medical Device Consultants, Inc. Welcomes Brian Edwards, Senior Regulatory Staff Consultant
Date:7/19/2011

NORTH ATTLEBORO, Mass., July 19, 2011 /PRNewswire/ -- Medical Device Consultants, Inc. (MDCI), a leading regulatory consulting firm and CRO for the medical device industry, announced today that Mr. Brian Edwards has joined the company's regulatory services group as a senior regulatory staff consultant. He will be based in Minneapolis, MN.

Mr. Edwards brings over twenty years of experience in the regulation of medical devices, design and analysis of device trials, biostatistics, quality systems, and US and OUS regulatory submissions. His work spans a broad range of therapeutic areas including work with spinal, audiological, cardiovascular, cardiology, muscle and nerve stimulation, urological, and software/communication devices.  During his previous positions as director of regulatory affairs at Zimmer Spine, Inc., Otologics, LLC, and Stereotaxis, Inc., as well as a senior level position with Medtronic, Inc. he managed regulatory clearances and approvals for Class II and Class III devices in the United States, European Union, Canada, Latin America and Asia. In addition, he is experienced in the implementation and auditing of FDA and ISO compliant quality systems.  

"I am pleased to welcome Brian to our team," said Vicki Anastasi, vice president of regulatory services and business development. "He brings proven regulatory expertise in key therapeutic areas, including cardiovascular, orthopedics and medical device software. Based in Minneapolis, he will amplify MDCI's presence in the important Twin Cities medical device cluster."

Brian holds a B.S. in chemical engineering, and an M.S. in biomedical engineering, both from the University of Minnesota. He also earned an M.S. in biostatistics from the University of California, Los Angeles.  Brian is a member of the Regulatory Affairs Professionals Society (RAPS).

About MDCI

Founded in 1980, MDCI is a full-service regulatory consulting firm and contract research organization (CRO) that helps emerging and established firms commercialize novel and innovative medical devices, in vitro diagnostics, and combination products.  Clients trust MDCI to deliver customized strategic guidance and creative "hands-on" solutions to address their unique regulatory, clinical trial, and quality assurance challenges at every stage of the product lifecycle.  MDCI has helped hundreds of clients conduct successful clinical trials, achieve regulatory clearance and approval, and maintain compliance for products in the U.S. and internationally.  MDCI has offices in Massachusetts and California.  Additional information is available at www.mdci.com.


'/>"/>
SOURCE Medical Device Consultants, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Outlines Oversight of Mobile Medical Applications
2. China Sky One Medical Wins Bidding Process on Land Use Rights Covering Land at Song Bei District in Harbin
3. Key Challenges for Pharma Medical Affairs Functions Include Budget & Headcounts
4. AAPC Physician Services Announces Medical Compliance Toolkit
5. European Medical Displays Markets
6. China Medical Technologies Announces the Filing of its Annual Report on Form 20-F for the Fiscal Year Ended March 31, 2011 with the SEC
7. HASCO Medical Announces New Redesigned Websites for Mobility Freedom and Wheelchair Vans of America
8. Mindray Medical Provides Mid-Year Update on Product Development
9. Aethlon Medical Releases Shareholder Letter
10. Aprima Earns High Marks at Holy Name Medical Center
11. QuantRx Biomedical Corporation Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it will release ... and host a conference call at 9:00am ET. The ... financial results and its strategy and outlook for the ... Erez Raphael , Chief Executive Officer, and ...
(Date:8/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... its Board of Directors has approved the payment of a ... 2017. The cash dividend ... October 27, 2017 to stockholders of record as of the ... dividends are subject to approval of the Board of Directors ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, ... company active in the biopharmaceutical, nutraceutical, and aquacultural ... development of its lead drug candidates, AGR131.  This ... proinflammatory cytokine from the blood of patients suffering ... and inflammatory bowel disease. ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... , ... Maury Regional Health has announced a large-scale adoption of AccuVein vein ... Maury Regional Medical Center is making vein visualization part of their standard of care. ... more importantly, helps our staff members locate a vein that will provide good access ...
(Date:8/16/2017)... ... August 16, 2017 , ... With a new PD ... ultimately, a cure. , The grants are awarded through a competitive application process ... a wide array of backgrounds and expertise in all areas relevant to PD research. ...
(Date:8/16/2017)... Sacramento, CA (PRWEB) , ... August 16, 2017 ... ... ($10.99, paperback, 9781498499613; $5.99, eBook, 9781498499620    ) shares that during the time of a ... as reminding Strawn of God's love, and all the many ways God shows ...
(Date:8/16/2017)... ... August 16, 2017 , ... Women’s Excellence in ... pain. In addition to oncology services, the new center will specialize in ... heavy bleeding during menstruation), uterine fibroids, and uterine and pelvic adhesions (scar tissue). ...
(Date:8/16/2017)... ... ... pain afflicting 8 of 10 Americans at some point in their lives, some of us ... equally vexing condition stems from a variety of causes that can be effectively targeted by ... president of Atlantic Spine Center. , Nestled between your neck and lower back, the ...
Breaking Medicine News(10 mins):